LPL Financial’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-39,307
| Closed | -$6.88K | – | 4616 |
|
|
2022
Q4 | $6.88K | Sell |
39,307
-16,990
| -30% | -$2.97K | ﹤0.01% | 4408 |
|
|
2022
Q3 | $24K | Sell |
56,297
-7,544
| -12% | -$3.22K | ﹤0.01% | 4275 |
|
|
2022
Q2 | $54K | Buy |
63,841
+13,689
| +27% | +$11.6K | ﹤0.01% | 4195 |
|
|
2022
Q1 | $276K | Buy |
50,152
+21,422
| +75% | +$118K | ﹤0.01% | 3614 |
|
|
2021
Q4 | $278K | Buy |
28,730
+513
| +2% | +$4.96K | ﹤0.01% | 3724 |
|
|
2021
Q3 | $505K | Sell |
28,217
-7,628
| -21% | -$137K | ﹤0.01% | 3187 |
|
|
2021
Q2 | $875K | Sell |
35,845
-8,330
| -19% | -$203K | ﹤0.01% | 2671 |
|
|
2021
Q1 | $1.17M | Sell |
44,175
-2,425
| -5% | -$64.3K | ﹤0.01% | 2254 |
|
|
2020
Q4 | $354K | Buy |
46,600
+6,000
| +15% | +$45.6K | ﹤0.01% | 3065 |
|
|
2020
Q3 | $203K | Buy |
40,600
+5,495
| +16% | +$27.5K | ﹤0.01% | 3172 |
|
|
2020
Q2 | $210K | Buy |
35,105
+3,226
| +10% | +$19.3K | ﹤0.01% | 3072 |
|
|
2020
Q1 | $142K | Buy |
31,879
+9,953
| +45% | +$44.3K | ﹤0.01% | 2904 |
|
|
2019
Q4 | $208K | Buy |
21,926
+4,361
| +25% | +$41.4K | ﹤0.01% | 3061 |
|
|
2019
Q3 | $138K | Buy |
17,565
+6,970
| +66% | +$54.8K | ﹤0.01% | 3102 |
|
|
2019
Q2 | $167K | Sell |
10,595
-2,720
| -20% | -$42.9K | ﹤0.01% | 3057 |
|
|
2019
Q1 | $241K | Buy |
13,315
+3,220
| +32% | +$58.3K | ﹤0.01% | 2795 |
|
|
2018
Q4 | $162K | Buy |
+10,095
| New | +$162K | ﹤0.01% | 2855 |
|